Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Dietary Intervention Shows Promise in Blood Cancers

2.

Study suggests radiation therapy benefits misjudged when clinical factors alone guide breast cancer treatment

3.

How to keep your prostate healthy and lower your risk of developing serious problems

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Preventable pediatric cancer mortality surges in areas of armed conflict, exceeding rates in non-conflict regions


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot